The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...

The FTC said it was also troubled by the role played by drug manufacturers such as Eli Lilly, Novo Nordisk ... inflated drug prices at the expense of pharmacies and patients. The company is demanding ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Novo Nordisk (NVO – Research Report) yesterday and set a price target of ...

In a report released today, Srikripa Devarakonda from Truist Financial assigned a Buy rating to Cytokinetics (CYTK – Research Report).

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month. Novo Nordisk's Wegovy Gets EU Backing to Treat ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...